Table 3.
Modulator | Model system | Effect on ROS |
Effect on autophagy |
Outcome | Conclusion of ROS-autophagy relationship |
Ref |
---|---|---|---|---|---|---|
PFT-μ + NVP-AUY922 | Melanoma cells & xenograft model |
Induction | Inhibition | Apoptosis; decreased tumor growth |
ER stress, ROS induction and autophagy inhibition |
[43] |
Graveoline | Melanoma cells | Induction | Induction | Apoptosis | ROS generation upstream of autophagy |
[76] |
Hydroxychloroquine (HCQ) + temozolomide (TMZ) |
Metastatic melanoma patients |
TMZ induce ROS |
Inhibition | Stabilized disease and response |
Therapeutic potential of combination compared to TMZ alone |
[85] |
Polygonatum cyrtonema lectin (PCL) |
Melanocytes Melanoma cells |
Induction | Induction | Apoptosis | Glutathione depletion, mitochondrial ROS and induction of autophagy |
[96] |
Cisplatin | Human melanoma cells | Induction | Inhibition | Apoptosis | ROS generation and inhibition of Beclin1/LC3B-mediated autophagic response |
[97] |
Physalin A | Melanoma cells | Induction | Induction | Apoptosis | ROS generation, autophagy induction |
[98] |
Fisetin | Melanoma cells | Induction | Transient induction |
Apoptosis | ER stress and ROS generation, autophagy induction |
[99] |
Usnea barbata | B16 mouse melanoma | Induction | Induction | Apoptosis | Oxidative stress induces autophagosomes and apoptosis |
[100] |